                         SEQUENCE LISTING

<110>  H. Lee Moffitt Cancer Center & Research Institute, Inc.
       Morse, David l
       Gillies, Robert J
       Huynh, Amanda
       Vagner, Josef
 
<120>  Molecular Imaging of Cancer Cells In Vivo

<130>  MOF 11MB064 PCT

<150>  US 61/533,198
<151>  2011-09-10

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  1
ctggcatcat gtatttaggg gc                                                22


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  2
gagttgcgcc tgtcagaaac                                                   20


<210>  3
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  3
cttcttcaag agttcataga cgac                                              24


<210>  4
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  4
tgctcagagt ttcatccgtt tg                                                22


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  5

Ser Arg Phe Asp Glu Asp Asp Leu Glu 
1               5                   


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  6

Gly Ser Gln Asn Leu Ala Ser Leu Glu Glu 
1               5                   10  


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  7
tctcccagtg tttggtgttg                                                   20


<210>  8
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  8
tggtgttcat tatcttccgc ag                                                22


<210>  9
<211>  104
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Met Arg Ser Phe Phe Ser Phe Leu Gly Glu Ala Phe Asp Gly Ala Arg 
1               5                   10                  15      


Asp Met Trp Arg Ala Tyr Ser Asp Met Arg Glu Ala Asn Tyr Ile Gly 
            20                  25                  30          


Ser Asp Lys Tyr Phe His Ala Arg Gly Asn Tyr Asp Ala Ala Lys Arg 
        35                  40                  45              


Gly Pro Gly Gly Val Trp Ala Ala Glu Ala Ile Ser Asp Arg Glu Asn 
    50                  55                  60                  


Ile Gln Arg Phe Phe Gly His Gly Ala Glu Asp Ser Leu Ala Asp Gln 
65                  70                  75                  80  


Ala Ala Asn Glu Trp Gly Arg Ser Gly Lys Asp Pro Asn His Phe Arg 
                85                  90                  95      


Pro Ala Gly Leu Pro Glu Lys Tyr 
            100                 


<210>  10
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Gly Asn Asn Asp Glu Ser Asn Ile Ser Phe Lys Glu Lys 
1               5                   10              


<210>  11
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  11

Cys Ser Lys Lys Lys Lys 
1               5       


